Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting
F Vernuccio, DS Gagliano, R Cannella… - Insights into …, 2021 - Springer
Hepatobiliary MRI contrast agents are increasingly being used for liver imaging. In clinical
practice, most focal liver lesions do not uptake hepatobiliary contrast agents. Less …
practice, most focal liver lesions do not uptake hepatobiliary contrast agents. Less …
Hepatocellular adenomas: Molecular basis and multimodality imaging update
Hepatocellular adenomas (HCAs) are a family of liver tumors that are associated with
variable prognoses. Since the initial description of these tumors, the classification of HCAs …
variable prognoses. Since the initial description of these tumors, the classification of HCAs …
New MRI features improve subtype classification of hepatocellular adenoma
S Bise, N Frulio, A Hocquelet, N Alberti, JF Blanc… - European …, 2019 - Springer
Objective MRI is crucial for the classification of hepatocellular adenomas (HCA) into
subtypes. Our objective was to review and increase MRI criteria for subtype classification …
subtypes. Our objective was to review and increase MRI criteria for subtype classification …
Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter …
F Ding, M Huang, P Ren, J Zhang, Z Lin, Y Sun… - European …, 2024 - Springer
Objectives To investigate the value of quantitative parameters derived from gadobenate
dimeglumine–enhanced magnetic resonance imaging (MRI) for predicting molecular …
dimeglumine–enhanced magnetic resonance imaging (MRI) for predicting molecular …
OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd‐EOB‐DTPA uptake and correlates with risk of malignancy
A Sciarra, S Schmidt, A Pellegrinelli… - Liver …, 2019 - Wiley Online Library
Abstract Background and Aims Hepatobiliary phase (HBP) Gd‐EOB‐DTPA‐enhanced
magnetic resonance imaging (MRI) has increased the accuracy in differentiating focal …
magnetic resonance imaging (MRI) has increased the accuracy in differentiating focal …
Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma
E Reizine, M Ronot, M Ghosn, J Calderaro, N Frulio… - European …, 2021 - Springer
Objectives To assess the value of hepatospecific MR contrast agent uptake on hepatobiliary
phase (HBP) images to detect marked activation of the β-catenin pathway in hepatocellular …
phase (HBP) images to detect marked activation of the β-catenin pathway in hepatocellular …
Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium–Enhanced MRI Features With Proposal of a …
Please see the Editorial Comment by Richard Kinh Gian discussing this article. To listen to
the podcast associated with this article, please select one of the following: iTunes, Google …
the podcast associated with this article, please select one of the following: iTunes, Google …
Hepatocellular adenomas: understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach
M Zulfiqar, CB Sirlin, N Yoneda, M Ronot… - Journal of Magnetic …, 2020 - Wiley Online Library
Hepatocellular adenomas (HCAs) are benign hepatic tumors that can be complicated by
bleeding and/or malignant transformation. The epidemiology of HCAs has changed over …
bleeding and/or malignant transformation. The epidemiology of HCAs has changed over …
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable …
Objectives To compare the performance of the quantitative analysis of the hepatobiliary
phase (HBP) tumor enhancement in gadobenate dimeglumine (Gd-BOPTA)–enhanced MRI …
phase (HBP) tumor enhancement in gadobenate dimeglumine (Gd-BOPTA)–enhanced MRI …
Iso-or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor …
E Reizine, M Ronot, F Pigneur, Y Purcell, S Mulé… - European …, 2019 - Springer
Purpose This study was conducted in order to evaluate if iso-or hyperintensity of HCAs on
HBP is systematically related to a high uptake of hepatospecific contrast agent, using a …
HBP is systematically related to a high uptake of hepatospecific contrast agent, using a …